Medication info
Ducarb Tablet 60/5 mg

Ducarb Tablet 60/5 mg

Prescription medicationTabletOral
Ingredient · strength
Fimasartan Potassium Trihydrate Granules›150mg / 1 tabletAmlodipine Besylate›6.94mg / 1 tablet
Manufacturer / importer
Boryung Pharmaceutical Co., Ltd.
Appearance
Yellow apple-shaped film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201603070 · Approved 2016.05.30 · Insurance code 641906480

Summary

Main use
Treatment of essential hypertension not controlled with fimasartan potassium monotherapy
Who takes it
Adults · Children
Adult dose
Adults The recommended dose of this medicine is 1 tablet once daily, taken with water regardless of meals. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. It is recommended that the dose be adjusted using fimasartan before starting this medicine. However, switching directly to this medicine may be considered if blood pressure is not controlled, as follows: ㆍ 30/5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 30/10 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy or 30/5 mg. ㆍ 60/5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. ㆍ 60/10 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy or 60/5 mg. Patients taking fimasartan and amlodipine concomitantly may switch to this medicine (a combination product with the same amounts of each active ingredient) for convenience. Older adults No initial dose adjustment is necessary in older adults aged 70 years or younger. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with fimasartan 30 mg in this medicine. Patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.
Child dose
The safety and efficacy of this medicine have not been established in pediatric and adolescent patients aged 18 years or younger.

Ingredients

Manufacturer
Boryung Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with fimasartan potassium monotherapy

  • Essential hypertension
View approved original text

Pimasartan potassium is used to treat essential hypertension and is utilized as an additional treatment option when blood pressure is not adequately controlled by monotherapy. This medication effectively lowers blood pressure, aiding in the management of hypertension.

How to take

Adult dose

Adults The recommended dose of this medicine is 1 tablet once daily, taken with water regardless of meals. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. It is recommended that the dose be adjusted using fimasartan before starting this medicine. However, switching directly to this medicine may be considered if blood pressure is not controlled, as follows: ㆍ 30/5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 30/10 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy or 30/5 mg. ㆍ 60/5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. ㆍ 60/10 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy or 60/5 mg. Patients taking fimasartan and amlodipine concomitantly may switch to this medicine (a combination product with the same amounts of each active ingredient) for convenience. Older adults No initial dose adjustment is necessary in older adults aged 70 years or younger. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with fimasartan 30 mg in this medicine. Patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.

Child dose

The safety and efficacy of this medicine have not been established in pediatric and adolescent patients aged 18 years or younger.

Precautions

This medication poses significant risk of serious harm or death to the fetus or newborn if taken during the second and third trimester of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Patients allergic to this drug's active ingredients or similar substances, women who are pregnant or breastfeeding, patients undergoing kidney dialysis, patients with moderate to severe liver impairment, patients with bile duct obstruction, certain diabetes patients with severely reduced kidney function, lactose intolerant patients, patients with severe aortic stenosis, and patients in shock should not use this drug. Patients with reduced blood volume or sodium, patients with impaired kidney function, patients with renovascular hypertension, patients with aortic or mitral stenosis or heart disease, patients with primary aldosteronism, patients with severe hypotension, elderly patients, and patients with a history of allergy to specific dyes contained in this medication should use it cautiously. While taking this medication, side effects such as dizziness, headache, facial swelling, urinary disorder, insomnia, and flushing may occur, and in rare cases, severe kidney problems or blood pressure drops may manifest. It is important to be aware of hypotension symptoms, especially in patients taking large amounts of diuretics or with restricted salt intake, as blood pressure may drop too low or electrolyte imbalances may occur. This drug may interact with other antihypertensives, potassium-sparing diuretics, lithium, and non-steroidal anti-inflammatory drugs, so any other medications being taken should be disclosed. In case of pregnancy or breastfeeding, this drug can be harmful to the fetus or baby, and consultation with a physician is necessary. Safety for children and adolescents under 18 years old has not been established. Generally, dosage adjustments are not necessary for the elderly, but caution is required as they may be more sensitive to the medication depending on the individual. It is safest not to use this medication in patients with moderate to severe liver impairment. In case of overdose, symptoms may include hypotension, cardiac arrhythmias, and in severe cases, shock, requiring immediate medical help. Store this drug out of reach of children and do not transfer it to another container to maintain quality. Dizziness or drowsiness may occur while taking this medication, requiring caution during driving or operating hazardous machinery.

Side effects

  • Dizziness
  • orthostatic dizziness
  • headache
  • facial swelling
  • peripheral edema
  • urinary disturbance
  • insomnia
  • flushing
  • syncope
  • sedation
Show 132 more
  • migraine
  • dyspepsia
  • vomiting
  • nausea
  • upper abdominal pain
  • weakness
  • foreign body sensation
  • elevated liver enzymes
  • decreased platelet count
  • increased serum creatine phosphokinase
  • cough
  • muscle contraction
  • musculoskeletal stiffness
  • itching
  • localized urticaria
  • facial flushing
  • erectile dysfunction
  • epilepsy
  • amyotrophic lateral sclerosis
  • neuropathy
  • neuronitis
  • facial paralysis
  • normal pressure hydrocephalus
  • spinal canal stenosis
  • acute pancreatitis
  • intestinal obstruction
  • hemorrhagic duodenal ulcer
  • appendicitis
  • hemorrhoids
  • abdominal pain
  • intracranial hemorrhage
  • transient ischemic attack
  • atherosclerosis
  • worsening cerebral infarction
  • cerebral hemorrhage
  • liver cancer
  • colon carcinoma
  • neoplasm of unspecified nature
  • cervical cancer
  • prostate cancer
  • acute renal failure
  • chronic renal failure
  • kidney stones
  • pyelonephritis
  • urinary incontinence
  • rhinitis
  • pulmonary fibrosis
  • pharyngitis
  • pneumonia
  • pulmonary disease
  • death
  • exacerbation of low back pain
  • osteoarthritis
  • arthropathy
  • hypoglycemia
  • hyperkalemia
  • pulmonary embolism
  • purpura
  • bradycardia
  • atrial fibrillation
  • coronary artery disease
  • aortic stenosis
  • heart failure
  • hypertension
  • acute hepatitis
  • benign pituitary neoplasm
  • otitis media
  • uterine prolapse
  • recurrent cancer
  • chest pain
  • weakness
  • fatigue
  • pain
  • weight gain
  • weight loss
  • heightened tension
  • sensory loss
  • sensory abnormality
  • peripheral neuropathy
  • taste disturbance
  • tremor
  • extrapyramidal disorder
  • gynecomastia
  • change in bowel habits
  • dry mouth
  • gingival hypertrophy
  • pancreatitis
  • hyperglycemia
  • arthralgia
  • low back pain
  • muscle cramps
  • myalgia
  • leukopenia
  • thrombocytopenia
  • cough
  • dyspnea
  • rhinitis
  • hair loss
  • hyperhidrosis
  • purpura
  • skin discoloration
  • urticaria
  • toxic epidermal necrolysis
  • tinnitus
  • visual disturbances
  • increased urinary frequency
  • urinary disturbance
  • nocturia
  • hepatitis
  • jaundice
  • elevated liver enzyme levels
  • pruritus
  • rash
  • vascular edema
  • erythema multiforme
  • myocardial infarction
  • arrhythmia
  • chest pain
  • hypotension
  • sinoatrial block
  • atrioventricular block
  • abdominal discomfort
  • precordial pain
  • diarrhea
  • loose stools
  • constipation
  • skin erythema
  • papular rash
  • heaviness
  • heat sensation
  • impaired glucose tolerance
  • weakness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and must be stored in a container that is light-resistant and sealed. It is important to maintain storage temperatures between 1 to 30 degrees Celsius. Storing it this way can help prolong the drug's effectiveness.

Appearance and packaging

Appearance

Yellow apple-shaped film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.